Obesity and pancreatic cancer: A matched-pair survival analysis

• Conditions: C25.9; E66.9; Pancreas, unspecified; Obesity, unspecified

• Registration Number: DRKS00021299
• Lead Sponsor: niversitätsklinikum Mannheim

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-12-31
• Study Start: 2020-04-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 152

Inclusion Criteria

Resection of a histologically proven pancreatic ductal adenocarcinoma. Recruiting time: 08-12-1997 - 12-27-2018.

Exclusion Criteria

Age < 18 years

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint was defined as the overall survival difference of patients with obesity and without obesity after resection of histologically confirmed PDAC.

Secondary Outcome Measures

Name	Time	Method
Secondary endpoints included intraoperative outcome, postoperative morbidity, pathological characteristics, postoperative length of hospital stay (LOS) and adjuvant chemotherapy.